Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Stanford Antimicrobial Safety and Sustainability program is recognized as an Infectious Diseases Society of America (IDSA) Center of Excellence and a World Health Organization (WHO) Collaborating Centre for Antimicrobial Resistance and Stewardship. The residency program will offer the resident clinical training and mentorship through a variety of experiences in infectious diseases and antimicrobial stewardship.
In addition to clinical practice experiences, the PGY-2 Infectious Disease resident will have the opportunity to participate in academic activities, which include an optional teaching certificate, precepting pharmacy residents/students, and providing didactic lectures to the Stanford Infectious Diseases Fellowship Program. The resident will also conduct a research project and engage in leadership development.
The Stanford Health Care PGY-2 Infectious Disease Residency Program is currently undergoing the accreditation process by American Society of Health-System Pharmacists (ASHP). One applicant is accepted per year.
Residency Contact Information
Residency Program Director: PGY-2 Infectious Diseases Program Director: Lina Meng, PharmD, BCCCP, BCIDP
Stanford Health Care
Department of Pharmacy
300 Pasteur Drive, Room H0301
Stanford, CA 94305-5616
The purpose of this residency program is to gain knowledge in infectious diseases pharmacotherapy and develop the skills needed to promote the safe and effective use of antimicrobials as a member of a multidisciplinary team.
Provide optimal clinical care to patients with infectious diseases
Function as an effective member of the health care team
Educate health care professionals, students, patients, and the community about antimicrobials and antimicrobial resistance
Develop excellent written and verbal communication skills
Demonstrate time management and problem-solving skills
Become a leader within the pharmacy profession
The Infectious Disease Specialty Residency is currently undergoing the accreditation process by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.
Orientation/Training (2-3 weeks)
General ID consult service (8 weeks)
Critical Care ID consult service (4 weeks)
Hematology/BMT ID consult service (4 weeks)
Solid Organ Transplant ID consult service (4 weeks)
Complete and present a longitudinal research project at a national conference
Complete and present findings of a quality improvement initiative
Development of an institutional clinical guideline or pathway
Participate in teaching activities with residents and/or students
Teaching certificate program (optional)
Participate in SHC Antimicrobial Subcommittee
Present a Continuing Education lecture to peers
Clinical staffing 1 weekend every 3 weeks
Compensation and Benefits
The resident will receive a competitive annual stipend of approximately $81,000 with full benefits, including an excellent health care benefits package and 10 days of paid time off (PTO). In addition, the resident will receive educational leave and a stipend to attend and participate in various pharmacy or infectious diseases conferences such as the ASHP Midyear Clinical Meeting in December and Infectious Diseases Society of America (IDWeek) meeting in October.
Completion of Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy
Completion of an ASHP-accredited PGY-1 residency program
Participate in an on-site interview at Stanford Health Care
Obtain licensure to practice pharmacy in the state of California before October 1st
Emily was born and raised in Glen Dale, West Virginia. She earned her Doctor of Pharmacy degree from West Virginia University School of Pharmacy in Morgantown, West Virginia. She then completed her PGY-1 pharmacy practice residency at Providence Portland Medical Center in Portland, Oregon. Emily is grateful and excited for the opportunity to continue her post-graduate training as the inaugural Infectious Diseases PGY-2 resident at Stanford Health Care. Her professional interests include antimicrobial resistance, infections in immunocompromised hosts, and clinical practice research. In her free time, Emily enjoys biking and hiking, live music and musicals, and spending time with friends and family.